|
575 Prexige licence
suspended after liver damage cases Pharmacists have been advised this week not to dispense Novartis's lumiracoxib (Prexige) and to return the product to their supplier following suspension of the product's marketing authorisation by the Medicines and Healthcare products Regulatory Agency
PJ 2007;279:575
Full Text
575 Minor ailments scheme on Government
agenda in Wales A national minor ailments
scheme for Wales may be on the horizon, Phil Parry, chief executive of
Community Pharmacy Wales, said this week
PJ 2007;279:575
Full Text
575 GPhC comes a step closer Legislation
to enable the creation of the General Pharmaceutical Council and transfer to
it the regulatory functions of the Royal Pharmaceutical Society has been tabled
in the House of Commons
PJ 2007;279:575
Full Text
575 Astellas distribution plans provoke concerns
for contract negotiators Pharmacy contract negotiators are worried that Astellas Pharma’s new distribution deal with UniChem will add another level of complexity to medicines ordering arrangements for pharmacists
PJ 2007;279:575
Full Text
576 Professional body must
represent all practice levels Equal representation
for pharmacy practitioners in all sectors of the profession and at all levels
will be required from the new professional body, according to members of the
UK Clinical Pharmacy Association who voiced their opinions at the UKCPA autumn
symposium, held in Leeds last week
PJ 2007;279:576
Full Text
576 Society’s fee increase may hamper progress of future professional body, says PSNC Development
of pharmacy's future professional body may be hampered by the Royal Pharmaceutical
Society's decision to increase fees for 2008 substantially, the Pharmaceutical
Services Negotiating Committee has warned
PJ 2007;279:576
Full Text
576 NHS organisations could learn from pharmacy’s commercial leadership skills Investment
in people and services needs to be made in the context of an overall vision for
an organisation, according to Justin Ash, managing director of Lloydspharmacy
PJ 2007;279:576
Full Text
576 BMA gives support to joint meetings with
PSNC Laurence Buckman, chairman of the British Medical Association’s general practitioners committee, has expressed support for joint meetings between GP and pharmacy contract negotiators
PJ 2007;279:576
Full Text
577 Society opposes MHRA stance
on pseudoephedrine Pharmacy bodies, including the
Royal Pharmaceutical Society, have opposed a Medicines and Healthcare products
Regulatory Agency proposal to take larger packs of pseudoephedrine- and ephedrine-containing
products off the pharmacy market earlier than originally recommended by the Commission
on Human Medicines
PJ 2007;279:577
Full Text
577 PHL launches series of public health posters New public health posters were launched by PharmacyHealthLink last week to mark the charity’s 21st anniversary. The posters complement resources published earlier this year
PJ 2007;279:577
Full Text
577 Novartis seeks pharmacy-medicine status
for diclofenac Novartis Consumer Health is seeking
the reclassification of low-dose diclofenac as a pharmacy medicine
PJ 2007;279:577
Full Text
577 New Nurse Prescribers' Formulary The latest edition of the Nurse Prescribers’ Formulary is published this month in a new 60-page booklet format
PJ 2007;279:577
Full Text
577 Diclofenac fails to speed recovery Neither
diclofenac nor spinal manipulative therapy reduces the time taken to recover
from acute lower-back pain, according to a study
PJ 2007;279:577
Full Text
577 Green health care competition Studies
into more environmentally friendly methods of providing health care are being
encouraged through an international competition announced by the BUPA Foundation
this week
PJ 2007;279:577
Full Text
578 SMC endorses use of epoetin
delta in Scotland Epoetin delta (Dynepo) is one
of four medicines that were accepted for use within NHS Scotland last week. A
further four medicines were rejected by the Scottish Medicines Consortium in
its latest round of appraisals
PJ 2007;279:578
Full Text
578 Scottish budget commits £97m to phase out prescription charges An investment of £97m over three years will be made to phase out NHS prescription charges in Scotland. This is one of the spending commitments set out by the Scottish Government in its budget last week
PJ 2007;279:578
Full Text
578 Pharmacy practice training body takes up
residence at London School of Pharmacy Pharmacy practice training and development continues to evolve in the south east of England with the Joint Programmes Board (JPB) for London, East and South East England taking up residence in London University School of Pharmacy’s advanced pharmacy studies centre
PJ 2007;279:578
Full Text
578 Polyclinics may create local health deserts Polyclinics could turn neighbourhoods into “health deserts”, the National Pharmacy Association has warned. In its response to an All-Party Parliamentary Primary Care and Public Health Group inquiry into GP access, the NPA welcomed strategies to increase capacity within general practice but voiced concerns that the Government-mooted polyclinic model could reduce people’s access to primary care in communities
PJ 2007;279:578
Full Text
579 Warning over allergic
reactions to strontium ranelate Women taking strontium
ranelate who develop a rash should stop taking the drug immediately and seek
medical advice, the Medicines and Healthcare products Regulatory Agency warned
last week
PJ 2007;279:579
Full Text
579 Pfizer letter advises on switch from Exubera Recommendations
for switching patients from Exubera inhaled insulin to other diabetes medicines
have been set out in a letter sent to health professionals
PJ 2007;279:579
Full Text
579 Greater awareness needed of obesity drug
depression risk Greater awareness of the potential
of rimonabant to induce symptoms of depression is needed, the authors of a Lancet
paper stress
PJ 2007;279:579
Full Text
579 Data fail to show differences in efficacy
of arthritis regimens There is no firm evidence
that any one regimen for rheumatoid arthritis is better than any other, according
to a systematic review published online this week
PJ 2007;279:579
Full Text
579 Treatment review needed for patients taking
carisoprodol Patients receiving treatment with
carisoprodol (Carisoma) should have their treatment reviewed following a decision
by the European Medicines Agency (EMEA) to suspend all marketing authorisations
for this medicine
PJ 2007;279:579
Full Text
579 Diabetes script costs up by 88 per cent
in five years Prescriptions for diabetes medicines
in England have risen by 55 per cent over the past five years and the cost of
these items has increased by 88 per cent, analysis by the Information Centre
has revealed
PJ 2007;279:579
Full Text
580 Pharmacists must tackle
all drug problems to provide effective care Pharmacists have to take responsibility for all patients’ drug therapy problems if they are to deliver effective pharmaceutical care, according to Linda Strand, professor of pharmaceutical care at the University of Minnesota, who spoke at the International Pharmaceutical Care Conference in Cracow, Poland, earlier this month
PJ 2007;279:580
Full Text
580 New model pharmacy opens at Lancashire university A new model pharmacy was opened this week at the University of Central Lancashire’s school of pharmacy and pharmaceutical sciences in Preston
PJ 2007;279:580
Full Text
580 All pharmacy staff can play a part in preventing
malnutrition Pharmacy staff in all sectors of the
profession should understand the benefits their interventions can have on the
nutritional status of their patients, according to Rebecca White, chairman of
the British Pharmaceutical Nutrition Group and pharmacy team manager, surgical
specialties and nutrition, Oxford Radcliffe Hospitals NHS Trust
PJ 2007;279:580
Full Text
580 Consensus on research and policy priorities
for chronic diseases published in Nature An
international panel has developed a list of 20 research and policy priorities
relating to chronic, non-communicable diseases, such as diabetes, stroke and
heart disease
PJ 2007;279:580
Full Text |
The
Pharmaceutical Journal